Newly approved does not always mean new and improved
JAMA
.
2008 Apr 2;299(13):1598-600.
doi: 10.1001/jama.299.13.1598.
Authors
Geoffrey M Anderson
1
,
David Juurlink
,
Allan S Detsky
Affiliation
1
Department of Health Policy Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
PMID:
18387934
DOI:
10.1001/jama.299.13.1598
No abstract available
MeSH terms
Clinical Trials as Topic
Drug Approval*
Drug Industry
Information Dissemination
Marketing
Patient Participation
Practice Patterns, Physicians'
Product Surveillance, Postmarketing*